| Dr Gregory W Heidrick, MD | |
|
9110 Andermatt Dr Ste 2, Lincoln, NE 68526-6701 | |
| (402) 483-7641 | |
| (402) 483-0527 |
| Full Name | Dr Gregory W Heidrick |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 40 Years |
| Location | 9110 Andermatt Dr Ste 2, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972688596 | NPI | - | NPPES |
| 47-0546525-12 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 17628 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Butler County Health Care Center | David city, NE | Hospital |
| Lincoln Surgical Hospital | Lincoln, NE | Hospital |
| Memorial Health Care Systems | Seward, NE | Hospital |
| Saunders Medical Center | Wahoo, NE | Hospital |
| Chi Health Schuyler | Schuyler, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lincoln Ob-gyn P.c. | 7315967270 | 8 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the company has completed its acquisition of Proteolix, Inc., a privately held biopharmaceutical company focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors.
Six decades of universal free health care, the introduction of widespread public health initiatives (eg, tobacco control, cancer screening, and immunisation), and substantial increases in health expenditure have failed to improve the UK's health outcomes or longevity ranking against the average of 14 other original members of the European Union, Australia, Canada, Norway, and the USA (EU15+) over the past 20 years.
Despite broad concern about heart disease as a leading cause of death in the United States, a recent survey of American adults sponsored by Nature Made and WomenHeart The National Coalition for Women with Heart Disease, found that many disregard taking some of the basic steps to support a healthy heart.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
› Verified 4 days ago
| Entity Name | Lincoln Ob-gyn P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811098841 PECOS PAC ID: 7315967270 Enrollment ID: O20051207000041 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the company has completed its acquisition of Proteolix, Inc., a privately held biopharmaceutical company focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors.
Six decades of universal free health care, the introduction of widespread public health initiatives (eg, tobacco control, cancer screening, and immunisation), and substantial increases in health expenditure have failed to improve the UK's health outcomes or longevity ranking against the average of 14 other original members of the European Union, Australia, Canada, Norway, and the USA (EU15+) over the past 20 years.
Despite broad concern about heart disease as a leading cause of death in the United States, a recent survey of American adults sponsored by Nature Made and WomenHeart The National Coalition for Women with Heart Disease, found that many disregard taking some of the basic steps to support a healthy heart.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory W Heidrick, MD 9110 Andermatt Dr Ste 2, Lincoln, NE 68526-6701 Ph: (402) 483-7641 | Dr Gregory W Heidrick, MD 9110 Andermatt Dr Ste 2, Lincoln, NE 68526-6701 Ph: (402) 483-7641 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the company has completed its acquisition of Proteolix, Inc., a privately held biopharmaceutical company focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors.
Six decades of universal free health care, the introduction of widespread public health initiatives (eg, tobacco control, cancer screening, and immunisation), and substantial increases in health expenditure have failed to improve the UK's health outcomes or longevity ranking against the average of 14 other original members of the European Union, Australia, Canada, Norway, and the USA (EU15+) over the past 20 years.
Despite broad concern about heart disease as a leading cause of death in the United States, a recent survey of American adults sponsored by Nature Made and WomenHeart The National Coalition for Women with Heart Disease, found that many disregard taking some of the basic steps to support a healthy heart.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
› Verified 4 days ago
Todd D Martin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6050 Village Dr, Lincoln, NE 68516 Phone: 402-421-8581 Fax: 402-421-8594 | |
Meggan L Linck, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1001 S 70th St Ste 220, Lincoln, NE 68510 Phone: 402-486-4800 Fax: 402-853-5465 | |
Dr. Yvonne K Davenport, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9110 Andermatt Dr Ste 2, Lincoln, NE 68526 Phone: 402-483-7641 Fax: 402-483-0527 | |
Dr. Torri Marie Janecek, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5055 A St Ste 200, Lincoln, NE 68510 Phone: 402-483-8630 Fax: 402-483-8578 | |
Sharon L Hier-duffin, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7001 A St, Ste 200, Lincoln, NE 68510 Phone: 402-488-4022 Fax: 402-488-4113 | |
Maureen Patrice Malee, MD PHD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1500 S 48th St, Suite 712, Lincoln, NE 68506 Phone: 402-483-8485 Fax: 402-483-8486 | |
Dr. Robert Thomas Byington, MD OBGYN Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1530s 70th St 100, Lincoln, NE 68506 Phone: 402-488-2348 Fax: 402-488-2463 |